How to Harmonize Stability Protocols Across Regulatory Agencies
Global pharmaceutical companies must align their stability testing protocols to meet the expectations of diverse regulatory agencies such as the USFDA, EMA, CDSCO, WHO, and ANVISA. This harmonization is crucial for streamlining global submissions, reducing duplicate studies, and accelerating market access. The primary keyword driving this process is stability protocol harmonization, anchored in ICH guidelines….
Read More “How to Harmonize Stability Protocols Across Regulatory Agencies” »
